To view enhanced content for this article go to http://www.medengine.com/Redeem/CB98F0607627E6CD.
Acinetobacter baumannii is an important human nosocomial pathogen; most clinical isolates are multidrug-resistant (MDR). Infections caused by A. baumannii often lead to high morbidity and mortality, with limited treatment options. Owing to the small number of anti-Gram-negative antibiotics in the development pipeline, researchers are looking to other natural compounds. The aim of this study was to determine the in vitro kill kinetics, in vivo efficacy and toxicity of theaflavin–epicatechin combinations against MDR A. baumannii.
Kill-kinetic assays were performed in Mueller–Hinton 2 broth over 24 h. Toxicity of the compound in the insect model, Galleria mellonella was investigated. The effect of theaflavin–epicatechin combinations on mortality and morbidity were assessed in Acinetobacter baumannii-infected G. mellonella. Larvae were scored for morbidity (melanisation: scale; 0–4) and mortality over 96 h.
Kill-kinetic assays revealed that monotherapy had bacteriostatic activity over 24 h, whereas theaflavin–epicatechin combinations were bactericidal (a >3 log reduction in bacterial numbers at 24 h compared with the starting inoculum). Both polyphenols were non-toxic to G. mellonella at concentrations of up to 1000 mg/kg. In vivo treatment assays showed that the combination significantly increased (t test; p ≤ 0.05) larval survival at 96 h to 86% [±17 standard deviation percentage points (pp)] compared to monotherapy with theaflavin (52% ± 14 pp), epicatechin (44% ± 25 pp) or PBS (31% ± 13 pp). Morbidity was also lower in larvae treated with the combination, compared with monotherapy.
Polyphenol combinations produce effective antibacterial action against A. baumannii and show great potential for the treatment of infections caused by MDR A. baumannii.
Friedmann M, Henika PR, Levin CE, Mandrill RE, Kozukue N. Antimicrobial activities of tea catechins and theaflavins and tea extracts against Bacillus cereus. J Food Prot. 2006;69(2):354–61. CrossRef
Cui Y, Kim SH, Kin H, Yeom J, Ko K, Park W, Park S. AFM probing the mechanism of synergistic effects of the green tea polyphenol (−)epigallocatechin-3-gallate (EGCG) with cefotaxime against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. PLoS ONE. 2012. doi: 10.1371/journal.pone.0048880.
Betts JW, Murphy C, Kelly SM, Haswell SJ. Minimum inhibitory and bactericidal concentrations of theaflavin and synergistic combinations with epicatechin and quercetin against clinical isolates of Stenotrophomonas maltophilia. J Microbiol Biotechnol Food Sci. 2012;1(5):1250–8.
Tsai CJ, Loh JM, Proft T. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing. Virulence. 2017;7(3):214–29. CrossRef
Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, Underwood A, Gaulton T, Thomas CP, Doumith M, Livermore DM, Woodford N. Whole-genome sequencing of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother. 2011;66(7):1499–503. CrossRefPubMed
Ozdal T, Capanoglu E, Altay FL. A review on protein–phenolic interactions and associated changes. Food Res Int. 2013;51(2):954–70. CrossRef
Lee KM, Kim WS, Lim J, Nam S, Youn M, Nam SW, Kim Y, Kim SH, Park W, Park S. Antipathogenic properties of green tea polyphenol epigallocatechin gallate at concentrations below the MIC against Enterohemorrhagic Escherichia coli O157:H7. J Food Protect. 2009;72(2):325–33. CrossRef
- In vitro and In vivo Activity of Theaflavin–Epicatechin Combinations versus Multidrug-Resistant Acinetobacter baumannii
Jonathan W. Betts
David W. Wareham
Roberto M. La Ragione
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II